These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3854057)

  • 1. The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension.
    Ando K; Ito Y; Noda H; Fujita T
    Jpn Circ J; 1985 Nov; 49(11):1151-8. PubMed ID: 3854057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K; Fujita T
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T
    Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril, aldosterone and urinary kallikrein in primary hypertension.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Clin Exp Hypertens A; 1983; 5(4):523-9. PubMed ID: 6342863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein and blood pressure--gender-different response to potassium supplementation in SHR. Role of aldosterone.
    Oddo EM; De Luca Sarobe V; Krmar R; Martín RS; Ibarra FR; Arrizurieta EE
    Nephron Physiol; 2008; 108(3):p37-45. PubMed ID: 18311071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased excretion of kallikrein during dexamethasone administration in normal man on low and normal salt intake.
    López JM; Arteaga E; Rodriguez JA; Croxatto H
    Clin Sci (Lond); 1983 Nov; 65(5):487-90. PubMed ID: 6555065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ
    J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
    Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
    Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertension.
    Overlack A; Stumpe KO; Moch B; Ollig A; Kleinmann R; Müller HM; Kolloch R; Krück F
    Klin Wochenschr; 1985 Apr; 63(8):352-60. PubMed ID: 3923252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of urinary kallikrein and plasma renin activities does not affect established hypertension in the fawn-hooded rat.
    Gilboa N; Rudofsky UH; Phillips MI; Magro AM
    Nephron; 1989; 51(1):61-6. PubMed ID: 2644567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.